Injectable GHK-Cu reaches follicle-depth tissue at 10 to 20 times the concentration of topical serums, making it more effective for moderate-to-advanced loss
16 In people with type 2 diabetes, over follow-up of 4050 weeks, tirzepatide 5 mg, 10 mg and 15 mg once weekly demonstrated: Superior HbA 1c reduction from baseline versus all comparators (see Table 1 )
doi:10.1016/S2213-8587(22)00085-7 16
doi: 10.1016/j.peptides.2006.05.011 Summary Keywords tirzepatide, suicide, obesity, psychiatry, diabets mellitus Citation Yu W-S, Huang J-Y, Lo S-C, Huang C-N, Yang Y-S and Kornelius E (2025) Association of tirzepatide and the risk of suicide in a real-world cohort
If patients receive GLP1 medications outside their primary health system (for example, from telehealth) or change providers during the treatment, the EHR data collected in our study may not capture the full course of treatment, and this may explain our observation of generally shorter treatment durations, and hence less weight loss, recorded in EHRs